ICU Medical Gets FDA Clearance for Infusion Pump-Software Combo
By Dean Seal
ICU Medical has received clearance from the U.S. Food and Drug Administration for its Plum Duo infusion pump with LifeShield infusion safety software.
The San Clemente, Calif.-based company said Tuesday that with the clearance, the Plum Duo pump and LifeShield software will be available to U.S. customers by early 2024.
The pump is the latest addition to the company's portfolio of infusion devices and features a large touch screen, highly intuitive user interface and two channels for delivering up to four compatible IV medications.
The LifeShield software is a cloud-based software suite providing tools for comprehensive drug library management.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
August 29, 2023 08:30 ET (12:30 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization